CD44 and neoplasm: Indeed, isolated CD44+/CD24−/lowLin− CSCs express a five-fold increase in BMI1 compared to tumour cells also derived from the same human breast carcinoma-derived xenograft tumour, but lacking CSC marker expression [118].